Structural Decoding of the Netrin-1/UNC5 Interaction and its Therapeutical Implications in Cancers

Overview of attention for article published in Cancer Cell, February 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

patent: 3 patents

Citations

dimensions_citation: 87 Dimensions

Readers on

mendeley: 124 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

NOVEL MCL-1 INHIBITOR AND COMBINATION OF MCL-1 AND A BH3 MIMETIC, SUCH AS A BCL-2…

Application WO-2023186968-A1

World Intellectual Property Organisation (WIPO)

ANTI-NETRIN-1 ANTIBODY TO TREAT LIVER INFLAMMATION

Application EP-4245772-A1

European Patent Office

COMBINATION THERAPY OF NTN1 NEUTRALIZING AGENT WITH DRUGS INHIBITING EPIGENETIC CONTROL

Application WO-2017076864-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.